by Stephen Manobiano | Jun 18, 2026 | Commercialization, Fractional, news
I’ve spent the last several months at life science conferences, dinners, and networking events, talking to founders, CEOs, and investors. And I keep hearing the same thing, just in different rooms. Investors are stuck with Portfolios they can’t exit. Which...
by Stephen Manobiano | Apr 9, 2026 | Commercialization, Fractional, Insight
The biggest advantage of fractional leadership is return on investment. Companies gain access to executives with decades of experience at a fraction of the cost of a full-time hire. Fractional leaders also bring: External perspective Industry networks Proven...
by Stephen Manobiano | Apr 8, 2026 | Commercialization, Insight, Sales
A defined sales process is essential for scaling a life science business. Organizations must standardize how they: Identify prospects Conduct discovery calls Deliver proposals Close deals Companies that implement structured processes consistently outperform those that...
by Stephen Manobiano | Apr 2, 2026 | Insight, Sales
High-performing life science sales teams focus on both quantitative activity and qualitative engagement. Successful teams track metrics such as: Discovery meetings Proposals submitted Conversion rates At the same time, they prioritize building long-term relationships...
by Stephen Manobiano | Mar 26, 2026 | Commercialization, Fractional, Insight
A fractional consultant can be valuable during several key phases of company growth: Pre-commercial launch Early revenue generation Market expansion Organizational restructuring During these phases, companies often need expertise in commercial strategy, marketing...
